Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Stealth BioTherapeutics Announces “Path Forward” Despite Disappointing Delay for Ultra-rare Barth Syndrome
      Biotech

      Stealth BioTherapeutics Announces “Path Forward” Despite Disappointing Delay for Ultra-rare Barth Syndrome

      May 29, 2025
      Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease
      Biotech

      Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease

      May 28, 2025
      EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
      Biotech

      EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO

      May 28, 2025
      Lunit Highlights AI’s Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies
      Biotech

      Lunit Highlights AI’s Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies

      May 27, 2025
      Global Single-Use Bioreactors Market Soars with 10.1% CAGR – Key Insights into Types & Applications | Valuates Reports
      Biotech

      Global Single-Use Bioreactors Market Soars with 10.1% CAGR – Key Insights into Types & Applications | Valuates Reports

      May 27, 2025
      Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025
      Biotech

      Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

      May 26, 2025
      New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
      Biotech

      New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

      May 24, 2025
      Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Four of Dynavax’s Highly Qualified Director Nominees
      Biotech

      Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Four of Dynavax’s Highly Qualified Director Nominees

      May 24, 2025
      Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting
      Biotech

      Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting

      May 23, 2025
      Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
      Biotech

      Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting

      May 23, 2025
      « 1 … 28 29 30 31 32 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026